These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Alternative Manufacturing Concepts for Solid Oral Dosage Forms From Drug Nanosuspensions Using Fluid Dispensing and Forced Drying Technology. Bonhoeffer B, Kwade A, Juhnke M. J Pharm Sci; 2018 Mar; 107(3):909-921. PubMed ID: 29154900 [Abstract] [Full Text] [Related]
24. The filling of molten and thixotropic formulations into hard gelatin capsules. Walker SE, Ganley JA, Bedford K, Eaves T. J Pharm Pharmacol; 1980 Jun; 32(6):389-93. PubMed ID: 6106669 [Abstract] [Full Text] [Related]
26. Biopharmaceutical challenges associated with drugs with low aqueous solubility--the potential impact of lipid-based formulations. O'Driscoll CM, Griffin BT. Adv Drug Deliv Rev; 2008 Mar 17; 60(6):617-24. PubMed ID: 18155800 [Abstract] [Full Text] [Related]
27. Lipid Based Formulations in Hard Gelatin and HPMC Capsules: a Physical Compatibility Study. Koehl NJ, Shah S, Tenekam ID, Khamiakova T, Sauwen N, Vingerhoets S, Coppenolle H, Holm R. Pharm Res; 2021 Aug 17; 38(8):1439-1454. PubMed ID: 34378150 [Abstract] [Full Text] [Related]
28. Modification of physicochemical characteristics of active pharmaceutical ingredients and application of supersaturatable dosage forms for improving bioavailability of poorly absorbed drugs. Kawakami K. Adv Drug Deliv Rev; 2012 May 01; 64(6):480-95. PubMed ID: 22265844 [Abstract] [Full Text] [Related]
32. Recent advances in intravenous delivery of poorly water-soluble compounds. Shi Y, Porter W, Merdan T, Li LC. Expert Opin Drug Deliv; 2009 Dec 01; 6(12):1261-82. PubMed ID: 19941409 [Abstract] [Full Text] [Related]
33. Formulation of fast release glibenclamide liquid and semi-solid matrix filled capsules. Galal S, El-Massik M, Abdallah O, Daabis N. Acta Pharm; 2003 Mar 01; 53(1):57-64. PubMed ID: 14769253 [Abstract] [Full Text] [Related]
35. Application of QbD principles for the evaluation of empty hard capsules as an input parameter in formulation development and manufacturing. Stegemann S, Connolly P, Matthews W, Barnett R, Aylott M, Schrooten K, Cadé D, Taylor A, Bresciani M. AAPS PharmSciTech; 2014 Jun 01; 15(3):542-9. PubMed ID: 24526655 [Abstract] [Full Text] [Related]
38. Effect of fill weight, capsule shell, and sinker design on the dissolution behavior of capsule formulations of a weak acid drug candidate BMS-309403. Wu Y, Zhao F, Paborji M. Pharm Dev Technol; 2003 Jun 01; 8(4):379-83. PubMed ID: 14601962 [Abstract] [Full Text] [Related]